Just encouraging isn't enough and won't get approval. If I'm not mistaken the FDA will be looking for conclusive data if comparing and trying to overthrow the SOC. Phase 2b better be perfectly designed IMO. Encouraging data = 1.85 post split.
Market Data 
Markets 
AI
